Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
HemostOD logo — Inspired by platelet biology to save lives.

HemostOD

Inspired by platelet biology to save lives.

Founded 2020 Switzerland Lausanne, Switzerland 8 employees Debt Financing Total: $2.20M Biotechnology, Manufacturing

General Information

Company Name HemostOD
Founded Year 2020
Location Switzerland Lausanne, Switzerland
Employees 8
Industries Biotechnology, Manufacturing
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with HemostOD. To contact HemostOD, visit hemostod.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does HemostOD compare?

A PDF of HemostOD and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting HemostOD soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About HemostOD

Hemostod is a biotechnology and manufacturing startup based in Switzerland, founded in 2020. The company's slogan, "Inspired by platelet biology to save lives," encapsulates its mission to utilize cutting-edge biotechnology in platelet engineering and manufacturing. In line with this vision, the company secured a Fr.1.70M Seed Round investment on 02 September 2021, with the backing of Orenok Holdings as the lead investor. Hemostod's focus on platelet biology presents a promising opportunity within the biotechnology and healthcare sectors, addressing critical needs in the field of blood-related therapies. The company's innovative approach, backed by recent investment, positions it well for further advancements in the space. As Hemostod continues to leverage its expertise in biotechnology and manufacturing, the recent Seed Round investment is instrumental in fueling the company's growth and R&D initiatives, ultimately driving impactful contributions to the field of life-saving biotechnologies.

Business keywords: platelets, bioengineering, stem cells, on demand, in vitro manufacturing, bioprocess, blood cancer, leukemia, transfusion, hematology, biologics, drug development, targeted drug delivery

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Fr.500.00K 1
Foundation for Technological Innovation (FIT)
11 Jun 2024
Seed Round Fr.1.70M 1
Orenok Holdings
02 Sep 2021

HemostOD Alternatives & Competitors

View All Alternatives
HemostOD vs
xcellbio
xcellbio United States

Improving therapeutic performance for predictive clinical outcomes through in vitro microenvironment...

Corporate Round
29 employees
Biotechnology, Health Care
HemostOD vs
LTS Lohmann Therapie-Systeme AG
LTS Lohmann Therapie-Systeme AG Germany

We CARE. We CREATE. We DELIVER.

Grant
326 employees
Biotechnology, Health Care
HemostOD vs
Catalent
Catalent United States

more products. better treatments. reliably supplied. ™

Post-IPO Debt
12614 employees
Biotechnology, Manufacturing
View all alternatives

FAQ About HemostOD

Inspired by platelet biology to save lives.
HemostOD was founded in 2020.
HemostOD is headquartered in Lausanne, Switzerland.
HemostOD operates in Biotechnology and Manufacturing. Its work centres on platelets, bioengineering, stem cells and on demand.
HemostOD has approximately 8 employees.
HemostOD has completed 2 funding rounds, raising a total of $2.20M. The latest funding stage is Debt Financing.
Top alternatives and competitors to HemostOD include xcellbio, LTS Lohmann Therapie-Systeme AG, Catalent, Innovent Biologics, Grand River Aseptic Manufacturing. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HemostOD and xcellbio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HemostOD, https://bouncewatch.com/company/hemostod, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout